Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DYNDET: Dynamic Symptom Networks in Depression Treatment
NCT07488910Phase 4Not yet recruiting
- Sponsor
- Goethe University Frankfurt
- Start
- Feb 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Goethe University Frankfurt. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07488910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07488910.